Javascript not supporting your browser
Resources and Tools Show/Hide
Clinical Monitoring
Welcome to Clinical Monitoring, the team that provides monitoring services on behalf of DMID. Sponsors of clinical investigations involving new drugs (including biological products for human use) and medical devices are required by federal regulations and ICH/GCP guidelines to monitor the progress of the clinical investigation under 21CFR Parts 312 and 812, and ICH GCP E6 (R2, Section 5.18).​​​
  
  
There are no items to show in this view of the "ClinicalMonitoring" document library.